The Swiss company Polygene would like to join a consortium for the following topic within the Work Programme 2016-2017 Health, Demographic Change and Wellbeing:
Within the call the company would like to contribute to the molecular and/or functional characterisation of the proposal to confirm diagnosis.
In general, the company's expertise lies in all kind of state-of-the-art genome engineering technologies for the generation of knock-out, knock-in or transgenic animals. Beside that the company evaluates its proprietary inducible expression systems in vivo for the inducible switch on/off of transgenic expression.
If you are interested, please contact Marlen Damjanovic